Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial.

Autor: Marmarelis ME; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Scholes DG; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., McWilliams TL; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA.; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA., Hwang WT; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA.; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA., Kosteva J; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Costello MR; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Sun L; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Singh AP; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Lau-Min KS; Division of Hematology-Oncology, Massachusetts General Cancer Center, Boston, MA., Doucette A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., Gabriel PE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Martella AO; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., Roy MA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Thompson JC; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Department of Pulmonary Medicine and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Cohen RB; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Dougherty DW; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Shulman LN; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., Langer CJ; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Bekelman JE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Carpenter EL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Aggarwal C; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2024 Dec; Vol. 20 (12), pp. 1620-1628. Date of Electronic Publication: 2024 Jul 03.

Gait assessment in the initial evaluation of posterior circulation stroke.

Autor: Smith I; Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA. Electronic address: Isaac.smith@nyulangone.org., Valdes E; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: Ehv2104@cumc.columbia.edu., Smith R; Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA. Electronic address: Rubin.smith@nyulangone.org., Cohen RB; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. Electronic address: Rachel.bandler@yale.edu., Torres J; Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA. Electronic address: Jose.torres2@nyulangone.org., Favate A; Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA. Electronic address: Albert.favate@nyulangone.org., Melmed KR; Department of Neurology, NYU Grossman School of Medicine, New York, NY, USA. Electronic address: Kara.melmed@nyulangone.org.

Publikováno v: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2024 Nov 16; Vol. 34 (1), pp. 108138. Date of Electronic Publication: 2024 Nov 16.

Association of oropharyngeal cancer recurrence with tumor-intrinsic and immune-mediated sequelae of reduced genomic instability.

Autor: Sannigrahi MK; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA., Raghav L; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA., Rich DJ; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA., Schrank TP; Department of Otorhinolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC., Califano JA; Department of Otolaryngology-Head and Neck Surgery, U. California San Diego, San Diego, CA., Lukens JN; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA., Sun L; Division of Hematology Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Morgan IM; Philips Institute for Oral Health Research and Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA., Cohen RB; Division of Hematology Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Lin A; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA., Liu X; Department of Pharmacology, University of Illinois at Chicago, Chicago, IL., Brown EJ; Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA., You J; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA.; Department of Microbiology, University of Pennsylvania, Philadelphia, PA., Mirabello L; Division of Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD., Mishra SK; Division of Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD., Shimunov D; Department of Otolaryngology-Head and Neck Surgery, Stony Brook, NY., Brody RM; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA., Pearson AT; Department of Medicine, University of Chicago Medical Center, Chicago, IL., Gimotty PA; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA., Diab A; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA.; Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA., Jalaly JB; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA., Basu D; Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, PA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.

Single-Institution Experience of Larotrectinib Therapy for Patients With NTRK Fusion-Positive Thyroid Carcinoma.

Autor: Elghawy O; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Barsouk A; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Heidlauf A; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Chen S; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Cohen RB; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Sun L; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.

Publikováno v: Journal of the Endocrine Society [J Endocr Soc] 2024 Sep 09; Vol. 8 (10), pp. bvae158. Date of Electronic Publication: 2024 Sep 09 (Print Publication: 2024).

Overall Survival, Treatment Duration, and Rechallenge Outcomes With ICI Therapy for Recurrent or Metastatic HNSCC.

Autor: Sun L; Division of Hematology Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Cohen RB; Division of Hematology Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., D'Avella CA; Division of Hematology Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Singh AP; Division of Hematology Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia., Schoenfeld JD; Dana Farber Cancer Institute, Boston, Massachusetts.; Brigham and Women's Hospital, Boston, Massachusetts., Hanna GJ; Dana Farber Cancer Institute, Boston, Massachusetts.

Publikováno v: JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2428526. Date of Electronic Publication: 2024 Aug 01.